Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.617329/full |
_version_ | 1818928793022103552 |
---|---|
author | Lisa Bartmann Lisa Bartmann David Schumacher Saskia von Stillfried Marieke Sternkopf Setareh Alampour-Rajabi Marc A. M. J. van Zandvoort Marc A. M. J. van Zandvoort Fabian Kiessling Zhuojun Wu Zhuojun Wu |
author_facet | Lisa Bartmann Lisa Bartmann David Schumacher Saskia von Stillfried Marieke Sternkopf Setareh Alampour-Rajabi Marc A. M. J. van Zandvoort Marc A. M. J. van Zandvoort Fabian Kiessling Zhuojun Wu Zhuojun Wu |
author_sort | Lisa Bartmann |
collection | DOAJ |
first_indexed | 2024-12-20T03:34:33Z |
format | Article |
id | doaj.art-1a846cc50c1142b2b15b79d0040ab993 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-20T03:34:33Z |
publishDate | 2020-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-1a846cc50c1142b2b15b79d0040ab9932022-12-21T19:54:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-11-011110.3389/fphar.2020.617329617329Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and TheranosticsLisa Bartmann0Lisa Bartmann1David Schumacher2Saskia von Stillfried3Marieke Sternkopf4Setareh Alampour-Rajabi5Marc A. M. J. van Zandvoort6Marc A. M. J. van Zandvoort7Fabian Kiessling8Zhuojun Wu9Zhuojun Wu10Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute of Pathology, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyDepartment of Genetics and Molecular Cell Biology, School for Cardiovascular Diseases (CARIM), School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, NetherlandsInstitute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germanyhttps://www.frontiersin.org/articles/10.3389/fphar.2020.617329/fullriboflavinRFVTtheranosticnanocarriercancer therapytargeting molecules |
spellingShingle | Lisa Bartmann Lisa Bartmann David Schumacher Saskia von Stillfried Marieke Sternkopf Setareh Alampour-Rajabi Marc A. M. J. van Zandvoort Marc A. M. J. van Zandvoort Fabian Kiessling Zhuojun Wu Zhuojun Wu Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics Frontiers in Pharmacology riboflavin RFVT theranostic nanocarrier cancer therapy targeting molecules |
title | Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics |
title_full | Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics |
title_fullStr | Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics |
title_full_unstemmed | Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics |
title_short | Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics |
title_sort | corrigendum evaluation of riboflavin transporters as targets for drug delivery and theranostics |
topic | riboflavin RFVT theranostic nanocarrier cancer therapy targeting molecules |
url | https://www.frontiersin.org/articles/10.3389/fphar.2020.617329/full |
work_keys_str_mv | AT lisabartmann corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT lisabartmann corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT davidschumacher corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT saskiavonstillfried corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT mariekesternkopf corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT setarehalampourrajabi corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT marcamjvanzandvoort corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT marcamjvanzandvoort corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT fabiankiessling corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT zhuojunwu corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics AT zhuojunwu corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics |